Emerging data technologies in life sciences
The UK Bioscience Forum will return in October 2020 as a two day virtual event, with the theme emerging data technologies.
Recent years have seen an explosion of emerging data technologies in the biotech sector. Many of these address long-standing challenges in the industry, offering the potential to reduce the time and cost of drug discovery, and to target beyond what was previously possible. But new opportunities bring new challenges. Ethical harnessing of data, access to and governance of data, skills and interoperability all provide significant hurdles.
Life science companies, keen to tap into computational power and access the potential of vast datasets, will need different capabilities to take the potential forward. Equally, technology-based organisations need to get to grips with the world of biotech in order to understand where they can add the most value.
Book today to join us in exploring the key issues of emerging technologies in our sector and connect with people who can help to take your organisation forwards.
Stratagem IPM Ltd
Stratagem Intellectual Property Management Ltd is a full-service, Cambridge UK-based, out sourced intellectual organisation and management company with global reach.
Consilium Strategic Communications
Consilium's principals have built their reputation in high level financial communications consultancy over the last 20 years. They have assembled a team of senior practitioners and consultants from established international public and investor relations agencies, as well as respected operators from investment banking, financial journalism, marketing and television.
As an independent financial communications consultancy, comprising only highly experienced advisers, Consilium is in a unique position to grow at the pace and demands of its client base. We are well-funded and financed; we don't need to chase fees for the sake of our investors and although we feature strongly in the league tables, that isn't how we judge ourselves. Instead, we measure success by the length and depth of our client relationships and successes, and by the growing number of our talented and experienced people. We can consider carefully the clients we take on and the commitments we make to them…for the long-term.
At Consilium the team you hire will be the one that works on your account, round-the-clock. Our people are committed to the business: your business."
There are 18 million people living with arthritis and related conditions in the UK. That’s one in four people, with half of those living in pain every single day. The impact is huge as the condition slowly intrudes on everyday life – affecting the ability to work, care for a family or move free from pain. Yet arthritis is often dismissed as an inevitable part of aging or shrugged off as ‘just a bit of arthritis’. We don’t think that this is ok. Versus Arthritis is here to change that.
Alongside volunteers, healthcare professionals, decision makers and researchers we do everything we can to push back against arthritis.
Together, we develop breakthrough treatments, campaign relentlessly for arthritis to be seen as a priority and support people with arthritis whenever they need it. We’re making real progress. But there’s still a long way to go, and we won’t stop until no-one has to tolerate the pain, fatigue and isolation of arthritis. We are Versus Arthritis.
Find out more at: www.versusarthritis.org
Professor Dame Ottoline LeyserUK Research and Innovation